Ethics Subcommittee, Advisory Committee to the Director, Centers for Disease Control and Prevention (CDC), 46610 [E9-21920]
Download as PDF
<![CDATA[
46610
Federal Register / Vol. 74, No. 174 / Thursday, September 10, 2009 / Notices
notify interested persons regarding their
request to speak by October 8, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact AnnMarie
Williams, Conference Management
Staff, 301–796–5966, at least 7 days in
advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: September 4, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–21810 Filed 9–9–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
erowe on DSK5CLS3C1PROD with NOTICES
Notice of Amendment—Public Meeting
of the AHRQ National Advisory Council
for Healthcare Research and Quality
Subcommittee On Quality Measures
for Children’s Healthcare in Medicaid
and Children’s Health Insurance
Programs
With this correction notice, the
Agency for Healthcare Research and
Quality (AHRQ) informs public of an
Amendment made to the notice subject
mentioned above which was published
on August 20, 2009, Vol. 74, No. 160,
pages 42079–42080, The amendment is
to add at the end of section
SUPPLEMENTARY INFORMATION, the
following: ‘‘As previously noted, the
meeting is open to the public and can
also be joined via Webcast. The link to
online registration for Webcast is
https://www.ConnectLive.com/events/
AHRQ2009.’’
VerDate Nov<24>2008
15:13 Sep 09, 2009
Jkt 217001
Dated: September 3, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–21690 Filed 9–9–09; 8:45 am]
BILLING CODE 4160–90–M
Dated: September 1, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–21920 Filed 9–9–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Ethics Subcommittee, Advisory
Committee to the Director, Centers for
Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following Subcommittee meeting:
Time and Date: 10:30 a.m.–12:30 p.m.,
September 24, 2009.
Place: The teleconference call will
originate at the Centers for Disease Control
and Prevention in Atlanta, Georgia. Please
see ‘‘Supplementary Information’’ for details
on accessing the teleconference.
Status: Open to the public, teleconference
access limited only by availability of
telephone ports. The public is welcome to
participate during the public comment
period which is tentatively scheduled from
12:15 p.m.–12:25 p.m.
Purpose: The Ethics Subcommittee will
provide counsel to the ACD, CDC, regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists and practitioners.
Matters To Be Discussed: The
teleconference agenda will include ethical
guidance for ventilator distribution during a
pandemic, update on CDC’s public health
ethics activities, and follow-up on
outstanding activities/reports.
Agenda items are subject to change as
priorities dictate.
Supplementary Information: This
conference call is scheduled to begin at
10:30 a.m. To participate in the
teleconference, please dial 1/866/919–
3560 and enter conference code
4168828. You will then be automatically
entered into the call.
Contact Person for More Information: Drue
Barrett, PhD, Designated Federal Officer,
Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D–50, Atlanta, Georgia
30333. Telephone (404/639–4690. E-mail:
dbarrett@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Clinical Resources.
Date: September 28, 2009.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Wendy F. Davidson, PhD,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIH/NIAID/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–8399, davidsonw@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–21791 Filed 9–9–09; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\10SEN1.SGM
10SEN1
]]>Agencies
[Federal Register Volume 74, Number 174 (Thursday, September 10, 2009)]
[Notices]
[Page 46610]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-21920]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Ethics Subcommittee, Advisory Committee to the Director, Centers
for Disease Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention announces the following Subcommittee meeting:
Time and Date: 10:30 a.m.-12:30 p.m., September 24, 2009.
Place: The teleconference call will originate at the Centers for
Disease Control and Prevention in Atlanta, Georgia. Please see
``Supplementary Information'' for details on accessing the
teleconference.
Status: Open to the public, teleconference access limited only
by availability of telephone ports. The public is welcome to
participate during the public comment period which is tentatively
scheduled from 12:15 p.m.-12:25 p.m.
Purpose: The Ethics Subcommittee will provide counsel to the
ACD, CDC, regarding a broad range of public health ethics questions
and issues arising from programs, scientists and practitioners.
Matters To Be Discussed: The teleconference agenda will include
ethical guidance for ventilator distribution during a pandemic,
update on CDC's public health ethics activities, and follow-up on
outstanding activities/reports.
Agenda items are subject to change as priorities dictate.
Supplementary Information: This conference call is scheduled to
begin at 10:30 a.m. To participate in the teleconference, please dial
1/866/919-3560 and enter conference code 4168828. You will then be
automatically entered into the call.
Contact Person for More Information: Drue Barrett, PhD,
Designated Federal Officer, Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D-50, Atlanta, Georgia 30333. Telephone (404/639-
4690. E-mail: dbarrett@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: September 1, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-21920 Filed 9-9-09; 8:45 am]
BILLING CODE 4163-18-P
